REGULATED PRESS RELEASE published on 07/08/2025 at 07:00, 6 months 23 days ago Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025 Biophytis SA announces participation in ARC 2025 to present results of BIO101 in sarcopenia at the World Aging & Rejuvenation Conference, aiming to strengthen scientific visibility and expand in the longevity market Sarcopenia Biophytis SA BIO101 Longevity Market ARC 2025
REGULATED PRESS RELEASE published on 07/08/2025 at 07:00, 6 months 23 days ago Biophytis au cœur de l’innovation dans la longévité à la conference World Aging & Rejuvenation 2025 Biophytis participe à la 7e conférence mondiale sur le vieillissement et le rajeunissement pour présenter ses résultats sur la sarcopénie et le candidat-médicament BIO101 Biophytis Conference Longévité BIO101 SARA Program
PRESS RELEASE published on 07/08/2025 at 06:59, 6 months 23 days ago Biophytis au cœur de l’innovation dans la longévité à la conference World Aging & Rejuvenation 2025 Biophytis annonce sa participation à la conférence World Aging & Rejuvenation 2025 à Vienne. Présentation des résultats du programme SARA sur la sarcopénie avec BIO101 Biophytis Longévité Sarcopénie World Aging & Rejuvenation 2025 SARA
BRIEF published on 07/07/2025 at 07:05, 6 months 24 days ago Biophytis : Avancée sur le Marché de l'Obésité Biophytis Marché Obésité GLP-1 Masse Musculaire
BRIEF published on 07/07/2025 at 07:05, 6 months 24 days ago Biophytis Aims to Address Muscle Loss in Obesity Market Biophytis BIO101 Muscle Preservation GLP-1 Therapies Obesity Market
REGULATED PRESS RELEASE published on 07/07/2025 at 07:00, 6 months 24 days ago Obesity: Biophytis Charts Its Course Toward a Booming Market Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market BIO101 Obesity Market Opportunity Muscle Loss Biophy.s SA
REGULATED PRESS RELEASE published on 07/07/2025 at 07:00, 6 months 24 days ago Obésité : Biophytis Trace sa Voie vers un Marché en Pleine Explosion BiophyFs SA saisit une opportunité majeure sur le marché de l'obésité en pleine expansion en développant des thérapies pour préserver la masse musculaire. Focusing sur BIO101 et l'importance de la préservation musculaire dans l'obésité BIO101 Obésité Thérapies Masse Musculaire BiophyFs SA
BRIEF published on 07/03/2025 at 07:05, 6 months 28 days ago Biophytis Showcases Innovations at BIO International 2025 Biophytis Precision Medicine Longevity Sarcopenia Obesity Therapy
BRIEF published on 07/03/2025 at 07:05, 6 months 28 days ago Biophytis : Avancées Thérapeutiques Présentées à la BIO International 2025 Biophytis Innovations Santé Thérapies Convention BIO 2025
REGULATED PRESS RELEASE published on 07/03/2025 at 07:00, 6 months 28 days ago Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025 Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact Innovations Longevity Obesity Muscle Health Biophy(s
Published on 01/31/2026 at 03:15, 12 hours 6 minutes ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 13 hours 1 minute ago Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 13 hours 41 minutes ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 16 hours 21 minutes ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 12:25, 2 hours 56 minutes ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 12 hours 36 minutes ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 17 hours 21 minutes ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 19 hours 11 minutes ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 19 hours 11 minutes ago Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 18:40, 20 hours 41 minutes ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 21 hours 36 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 21 hours 36 minutes ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 6 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés